» Articles » PMID: 38613073

A Free Amino Acid Diet Alleviates Colorectal Tumorigenesis Through Modulating Gut Microbiota and Metabolites

Overview
Journal Nutrients
Date 2024 Apr 13
PMID 38613073
Authors
Affiliations
Soon will be listed here.
Abstract

Colorectal cancer (CRC), a major global health concern, may be influenced by dietary protein digestibility impacting gut microbiota and metabolites, which is crucial for cancer therapy effectiveness. This study explored the effects of a casein protein diet (CTL) versus a free amino acid (FAA)-based diet on CRC progression, gut microbiota, and metabolites using carcinogen-induced (AOM/DSS) and spontaneous genetically induced ( mice) CRC mouse models. Comprehensive approaches including 16s rRNA gene sequencing, transcriptomics, metabolomics, and immunohistochemistry were utilized. We found that the FAA significantly attenuated CRC progression, evidenced by reduced colonic shortening and histopathological alterations compared to the CTL diet. Notably, the FAA enriched beneficial gut bacteria like and and reversed CRC-associated dysbiosis. Metabolomic analysis highlighted an increase in ornithine cycle metabolites and specific fatty acids, such as Docosapentaenoic acid (DPA), in FAA-fed mice. Transcriptomic analysis revealed that FAA up-regulated Egl-9 family hypoxia inducible factor 3 (Egln 3) and downregulated several cancer-associated pathways including Hippo, mTOR, and Wnt signaling. Additionally, DPA was found to significantly induce EGLN 3 expression in CRC cell lines. These results suggest that FAA modulate gut microbial composition, enhance protective metabolites, improve gut barrier functions, and inhibit carcinogenic pathways.

Citing Articles

Gut Microbiota-Adversary or Ally? Its Role and Significance in Colorectal Cancer Pathogenesis, Progression, and Treatment.

Chawrylak K, Lesniewska M, Mielniczek K, Sedlak K, Pelc Z, Pawlik T Cancers (Basel). 2024; 16(12).

PMID: 38927941 PMC: 11201452. DOI: 10.3390/cancers16122236.


mTOR: Its Critical Role in Metabolic Diseases, Cancer, and the Aging Process.

Marafie S, Al-Mulla F, Abubaker J Int J Mol Sci. 2024; 25(11).

PMID: 38892329 PMC: 11173325. DOI: 10.3390/ijms25116141.

References
1.
Siegel R, Torre L, Soerjomataram I, Hayes R, Bray F, Weber T . Global patterns and trends in colorectal cancer incidence in young adults. Gut. 2019; 68(12):2179-2185. DOI: 10.1136/gutjnl-2019-319511. View

2.
Center M, Jemal A, Ward E . International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev. 2009; 18(6):1688-94. DOI: 10.1158/1055-9965.EPI-09-0090. View

3.
Newell M, Mazurak V, Postovit L, Field C . N-3 Long-Chain Polyunsaturated Fatty Acids, Eicosapentaenoic and Docosahexaenoic Acid, and the Role of Supplementation during Cancer Treatment: A Scoping Review of Current Clinical Evidence. Cancers (Basel). 2021; 13(6). PMC: 8000768. DOI: 10.3390/cancers13061206. View

4.
Ogata Y, Ishibashi N, Yamaguchi K, Uchida S, Kamei H, Nakayama G . Preventive effects of amino-acid-rich elemental diet Elental® on chemotherapy-induced oral mucositis in patients with colorectal cancer: a prospective pilot study. Support Care Cancer. 2015; 24(2):783-789. PMC: 4689768. DOI: 10.1007/s00520-015-2844-0. View

5.
Kantor E, Lampe J, Peters U, Vaughan T, White E . Long-chain omega-3 polyunsaturated fatty acid intake and risk of colorectal cancer. Nutr Cancer. 2013; 66(4):716-27. PMC: 3961554. DOI: 10.1080/01635581.2013.804101. View